HLB Life Science CO.,LTD.
Develops anti-cancer drugs and manufactures in vitro diagnostic medical devices.
067630 | KO
Overview
Corporate Details
- ISIN(s):
- KR7067630004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 동탄첨단산업1로 51-9 8층(영천동,엠타워지식산업센터), 화성시
- Website:
- https://www.hlb-lsmc.com/
- Sector:
- Manufacturing
Description
HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-23 00:00 |
사업보고서 (2020.12)
|
Korean | 645.5 KB | ||
| 2021-03-12 00:00 |
권리락(무상증자)
|
Korean | 3.5 KB | ||
| 2021-03-02 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.5 KB | ||
| 2021-02-26 00:00 |
주요사항보고서(무상증자결정)
|
Korean | 8.8 KB | ||
| 2021-02-26 00:00 |
주권매매거래정지(무상증자)
|
Korean | 4.8 KB | ||
| 2021-02-26 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-02-25 00:00 |
주주총회소집결의
|
Korean | 14.4 KB | ||
| 2021-02-25 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.3 KB | ||
| 2021-02-25 00:00 |
의결권대리행사권유참고서류
|
Korean | 310.2 KB | ||
| 2021-02-25 00:00 |
주주총회소집공고
|
Korean | 295.5 KB | ||
| 2021-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.7 KB | ||
| 2020-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-11-27 00:00 |
합병등종료보고서(자산양수도)
|
Korean | 21.0 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | 1.5 MB | ||
| 2020-09-29 00:00 |
투자판단관련주요경영사항(파이로티닙(Pyrotinib - EGFR, HER2, HER4를 특이적으로 억제하는 표적항암제)의 한국 독점 라이선스 …
|
Korean | 12.9 KB |
Automate Your Workflow. Get a real-time feed of all HLB Life Science CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HLB Life Science CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB Life Science CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
